|
1
|
Zhang X, Li J, Shen F and Lau WY:
Significance of presence of microvascular invasion in specimens
obtained after surgical treatment of hepatocellular carcinoma. J
Gastroenterol Hepatol. 33:347–354. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB: Hepatocellular carcinoma: An
epidemiologic view. J Clin Gastroenterol. 35 (5 Suppl 2):S72–S78.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dutta R and Mahato RI: Recent advances in
hepatocellular carcinoma therapy. Pharmacol Ther. 173:106–117.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruix J, Reig M and Sherman M:
Evidence-based diagnosis, staging, and treatment of patients with
hepatocellular carcinoma. Gastroenterology. 150:835–853. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dhir M, Melin AA, Douaiher J, Lin C, Zhen
WK, Hussain SM, Geschwind JF, Doyle MB, Abou-Alfa GK and Are C: A
Review and update of treatment options and controversies in the
management of hepatocellular carcinoma. Ann Surg. 263:1112–1125.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ogretmen B and Hannun YA: Biologically
active sphingolipids in cancer pathogenesis and treatment. Nat Rev
Cancer. 4:604–616. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Obinata H and Hla T: Sphingosine
1-phosphate and inflammation. Int Immunol. 31:617–625. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kawamori T, Kaneshiro T, Okumura M,
Maalouf S, Uflacker A, Bielawski J, Hannun YA and Obeid LM: Role
for sphingosine kinase 1 in colon carcinogenesis. FASEB J.
23:405–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Go H, Kim PJ, Jeon YK, Cho YM, Kim K, Park
BH and Ku JY: Sphingosine-1-phosphate receptor 1 (S1PR1) expression
in non-muscle invasive urothelial carcinoma: Association with poor
clinical outcome and potential therapeutic target. Eur J Cancer.
51:1937–1945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vrzalikova K, Ibrahim M, Vockerodt M,
Perry T, Margielewska S, Lupino L, Nagy E, Soilleux E, Liebelt D,
Hollows R, et al: S1PR1 drives a feedforward signalling loop to
regulate BATF3 and the transcriptional programme of Hodgkin
lymphoma cells. Leukemia. 32:214–223. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang C, Mao J, Redfield S, Mo Y, Lage JM
and Zhou X: Systemic distribution, subcellular localization and
differential expression of sphingosine-1-phosphate receptors in
benign and malignant human tissues. Exp Mol Pathol. 97:259–265.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grammatikos G, Schoell N, Ferreirós N, Bon
D, Herrmann E, Farnik H, Köberle V, Piiper A, Zeuzem S,
Kronenberger B, et al: Serum sphingolipidomic analyses reveal an
upregulation of C16-ceramide and sphingosine-1-phosphate in
hepatocellular carcinoma. Oncotarget. 7:18095–18105. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoshiji H, Kuriyama S, Kawata M, Yoshii J,
Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H and Fukui H: The
angiotensin-I-converting enzyme inhibitor perindopril suppresses
tumor growth and angiogenesis: Possible role of the vascular
endothelial growth factor. Clin Cancer Res. 7:1073–1078.
2001.PubMed/NCBI
|
|
15
|
Nakai Y, Isayama H, Ijichi H, Sasaki T,
Sasahira N, Hirano K, Kogure H, Kawakubo K, Yagioka H, Yashima Y,
et al: Inhibition of renin-angiotensin system affects prognosis of
advanced pancreatic cancer receiving gemcitabine. Br J Cancer.
103:1644–1648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chowdhury A, Sarkar J, Pramanik PK,
Chakraborti T and Chakraborti S: Cross talk between
MMP2-Spm-Cer-S1P and ERK1/2 in proliferation of pulmonary artery
smooth muscle cells under angiotensin II stimulation. Arch Biochem
Biophys. 603:91–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tirapelli CR, Bonaventura D, Tirapelli LF
and de Oliveira AM: Mechanisms underlying the vascular actions of
endothelin 1, angiotensin II and bradykinin in the rat carotid.
Pharmacology. 84:111–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dolley-Hitze T, Verhoest G, Jouan F, Le
Pogamp P, Arlot-Bonnemains Y, Oger E, Belaud-Rotureau MA,
Rioux-Leclercq N and Vigneau C: Angiotensin-2 type 1 receptors
(AT1R) and cancers. Nephrol Ther. 9:85–91. 2013.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ji Y, Wang Z, Li Z, Zhang A, Jin Y, Chen H
and Le X: Angiotensin II enhances proliferation and inflammation
through AT1/PKC/NF-κB signaling pathway in hepatocellular carcinoma
cells. Cell Physiol Biochem. 39:13–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu YC, Ho HJ, Wu MS, Lin JT and Wu CY:
Postoperative peg-interferon plus ribavirin is associated with
reduced recurrence of hepatitis C virus-related hepatocellular
carcinoma. Hepatology. 58:150–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Facciorusso A, Del Prete V, Crucinio N,
Muscatiello N, Carr BI, Di Leo A and Barone M: Angiotensin receptor
blockers improve survival outcomes after radiofrequency ablation in
hepatocarcinoma patients. J Gastroenterol Hepatol. 30:1643–1650.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee DY, Won KJ, Lee KP, Jung SH, Baek S,
Chung HW, Choi WS, Lee HM, Lee BH, Jeon BH and Kim B: Angiotensin
II facilitates neointimal formation by increasing vascular smooth
muscle cell migration: Involvement of APE/Ref-1-mediated
overexpression of sphingosine-1-phosphate receptor 1. Toxicol Appl
Pharmacol. 347:45–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanai T, Hirohashi S, Upton MP, Noguchi M,
Kishi K, Makuuchi M, Yamasaki S, Hasegawa H, Takayasu K, Moriyama
N, et al: Pathology of small hepatocellular carcinoma. A proposal
for a new gross classification. Cancer. 60:810–819. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Liu P, Jiang Y, Dou X, Yan J, Ma
C, Fan Q, Wang W, Su F, Tang H and Su X: High expression of
neuropilin-1 associates with unfavorable clinicopathological
features in hepatocellular carcinoma. Pathol Oncol Res. 22:367–375.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhai X, Zhu H, Wang W, Zhang S, Zhang Y
and Mao G: Abnormal expression of EMT-related proteins, S100A4,
vimentin and E-cadherin, is correlated with clinicopathological
features and prognosis in HCC. Med Oncol. 31:9702014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ji Y, Wang Z, Chen H, Zhang L, Zhuo F and
Yang Q: Serum from chronic hepatitis B patients promotes growth and
proliferation via the IGF-II/IGF-IR/MEK/ERK signaling pathway in
hepatocellular carcinoma cells. Cell Physiol Biochem. 47:39–53.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abbott. Operations manual or user guide.
https://www.corelaboratory.abbott/registration-ous/login
|
|
30
|
Pyne NJ and Pyne S: Sphingosine
1-phosphate and cancer. Nat Rev Cancer. 10:489–503. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pinter M, Weinmann A, Wörns MA, Hucke F,
Bota S, Marquardt JU, Duda DG, Jain RK, Galle PR, Trauner M, et al:
Use of inhibitors of the renin-angiotensin system is associated
with longer survival in patients with hepatocellular carcinoma.
United European Gastroenterol J. 5:987–996. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ye G, Qin Y, Lu X, Xu X, Xu S, Wu C, Wang
X, Wang S and Pan D: The association of renin-angiotensin system
genes with the progression of hepatocellular carcinoma. Biochem
Biophys Res Commun. 459:18–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu ZW, Yan SX, Wu HX, Zhang Y and Wei W:
Angiotensin II and tumor necrosis factor-alpha stimulate the
growth, migration and invasion of BEL-7402 cells via
down-regulation of GRK2 expression. Dig Liver Dis. 51:263–274.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stoyanov E, Ludwig G, Mizrahi L, Olam D,
Schnitzer-Perlman T, Tasika E, Sass G, Tiegs G, Jiang Y, Nie T, et
al: Chronic liver inflammation modifies DNA methylation at the
precancerous stage of murine hepatocarcinogenesis. Oncotarget.
6:11047–11060. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kew MC: Epidemiology of chronic hepatitis
B virus infection, hepatocellular carcinoma, and hepatitis B
virus-induced hepatocellular carcinoma. Pathol Biol (Paris).
58:273–277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pyne NJ, Ohotski J, Bittman R and Pyne S:
The role of sphingosine 1-phosphate in inflammation and cancer. Adv
Biol Regul. 54:121–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bao M, Chen Z, Xu Y, Zhao Y, Zha R, Huang
S, Liu L, Chen T, Li J, Tu H and He X: Sphingosine kinase 1
promotes tumour cell migration and invasion via the S1P/EDG1 axis
in hepatocellular carcinoma. Liver Int. 32:331–338. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsushima-Nishiwaki R, Yamada N, Fukuchi
K and Kozawa O: Sphingosine 1-phosphate (S1P) reduces hepatocyte
growth factor-induced migration of hepatocellular carcinoma cells
via S1P receptor 2. PLoS One. 13:e02090502018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fong ZV and Tanabe KK: The clinical
management of hepatocellular carcinoma in the United States,
Europe, and Asia: A comprehensive and evidence-based comparison and
review. Cancer. 120:2824–2838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wong RJ, Devaki P, Nguyen L, Cheung R and
Nguyen MH: Ethnic disparities and liver transplantation rates in
hepatocellular carcinoma patients in the recent era: Results from
the Surveillance, Epidemiology, and End Results registry. Liver
Transpl. 20:528–535. 2014. View Article : Google Scholar : PubMed/NCBI
|
